Interleukin-2 (low-dose IL-2)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Interleukin-2 (low-dose IL-2), covering 2013-09-05 to 2021-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]